Clinical Trials Sponsored by Fresenius Kabi

Total 365 results

Fresenius Medical Care North America

Completed

Acid-Base Composition With Use of hemoDialysates (ABChD)

End Stage Renal Disease

United States
Fresenius Medical Care North America

Completed

Phosphate Kinetic Modeling (PKM)

End Stage Renal Disease | Hyperphosphatemia

United States
Fresenius Medical Care North America

Unknown

Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

Mortality | Anemia

United States
Kibi International University

Completed

Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Kibi International University

Completed

Effect of Positive-word Stimuli on the Limits of Stability During Multi-direction Reach Operation in Standing Position

Healthy

Japan
Kibi International University

Unknown

iPad Application-based Intervention for Post-stroke Depression

Post-stroke Depression

Japan
Kibi International University

Completed

Smartphone Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Kibi International University

Completed

Immediate Effect of Subliminal Priming With Subliminal Reward Stimuli on Standing Balance in Healthy Young Adults

Healthy
Nabi Biopharmaceuticals
GlaxoSmithKline

Completed

Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

Smoking Cessation

United States
Vifor Fresenius Medical Care Renal Pharma
Worldwide Clinical Trials; Fresenius Medical Care Deutschland GmbH

Terminated

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial (ANEMEX)

Anemia | End Stage Renal Disease

United Kingdom
KAI Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Hyperparathyroidism, Secondary

United States, Australia
Vifor Fresenius Medical Care Renal Pharma

Recruiting

Avacostar - (PASS) (Avacostar)

ANCA-associated Vasculitis

United Kingdom, Germany
Heidelberg University
Else Kröner Fresenius Foundation

Unknown

Controlling Femoral Derotation Osteotomy In Cerebral Palsy With Electromagnetic Tracking

Cerebral Palsy | Gait Disorders, Neurologic | Malalignment

Germany
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Neovii Biotech
Fresenius Biotech North America

Completed

Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy

Ovarian Cancer

United States
Neovii Biotech
Fresenius Biotech North America

Terminated

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy

Advanced Breast Cancer | Metastatic Breast Cancer

United States, Canada
Heidelberg University
Else Kröner Fresenius Foundation

Completed

Postoperative Delirium at Heidelberg's Intensive Care Unit -New Diagnostic Markers

Postoperative Delirium

Germany
Neovii Biotech
Fresenius Biotech North America

Completed

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Malignant Ascites

United States
Fresenius Medical Care North America
Amgen

Unknown

Care Transitions in Renal Disease Patients (CT)

Renal Disease

United States
Fresenius Medical Care North America
Abbott

Completed

Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients

Kidney Failure

United States
KAI Pharmaceuticals

Terminated

Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism
Vifor Fresenius Medical Care Renal Pharma

Completed

PA21 Safety and Efficacy in Adult Chinese Subjects

Hyperphosphatemia | Chronic Kidney Disease Requiring Chronic Dialysis

China
Heidelberg University
Else Kröner Fresenius Foundation

Unknown

Controlling Femoral Extension and Derotation Osteotomy In Cerebral Palsy With Electromagnetic Tracking

Cerebral Palsy | Malalignment | Interal Rotation Gait | Crouch Gait

Germany
Vifor Fresenius Medical Care Renal Pharma

Terminated

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Hyperphosphatemia

United States, Poland, Germany, Lithuania, France, Romania, Russian Federation
University Hospital, Basel, Switzerland
Fresenius AG

Completed

BaSES Trial: Basel Starch Evaluation in Sepsis (BaSES)

Sepsis | Septic Shock | Severe Sepsis

Switzerland
Waleed Khaild Rahman Kareem Al-kabi

Not yet recruiting

Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease

Uremic Toxin

Iraq
KAI Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
KAI Pharmaceuticals

Completed

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Secondary Hyperparathyroidism
KAI Pharmaceuticals

Completed

Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack

Myocardial Infarction

United States
Nabi Biopharmaceuticals
Vanderbilt University

Completed

Evaluation of Consistency of StaphVAX Manufacturing Lots

Staphylococcal Infections

United States
Johann Wolfgang Goethe University Hospital
University Hospital Muenster; CSL Behring; University Hospital, Bonn; B. Braun... and other collaborators

Completed

Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients (PBM)

Surgery

Germany
Hannover Medical School
Else Kröner Fresenius Foundation

Recruiting

Priming of the NEonatal Immune System by Transfer of Maternal Immunity (NEST)

COVID-19 | Respiratory Infections in Children | Maternal Vaccine Exposure

Germany
Fresenius Medical Care Deutschland GmbH
CERES GmbH

Recruiting

Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy (multiECCO2R)

Covid19 | Acute Kidney Injury | Acute Lung Injury | Hypercapnia

Germany
Fresenius Medical Care Deutschland GmbH
Alcedis GmbH

Recruiting

Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine (SEPIAR)

Autoimmune Diseases

Germany
University Hospital Muenster
Else Kröner Fresenius Foundation

Completed

Impact of Handover of Anesthesia Care on Adverse Postoperative Outcomes (HandiCAP)

Anesthesia | Adverse Effect of Handovers of Anesthesia Care

Germany
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, Belgium, Croatia, Austria, Czech Republic, Germany, Lithuania, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
Ege University
Fresenius Medical Care North America

Completed

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

Hemodialysis | End-stage Renal Disease

Turkey
Ege University
Fresenius Medical Care North America

Completed

Comparison of Four and Eight Hours Dialysis Sessions in Thrice Weekly Hemodialysis

Hemodialysis | End-Stage Renal Disease

Turkey
University Hospital, Saarland
Else Kröner Fresenius Foundation

Unknown

Effects of Hemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass Induced Immunosuppression

Inflammation

Germany
Pontifícia Universidade Católica do Paraná
Fresenius AG

Completed

Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes (HDFIT)

Chronic Kidney Disease

Brazil
University Hospital Muenster
Else Kröner Fresenius Foundation

Unknown

Remote Ischemic Preconditioning After Cardiac Surgery (RIPCRenal)

Cardiac Surgery, Aortocoronary Bypass

Germany
Ege University
Fresenius Medical Care North America

Completed

Effects Of Volume Control Guided by Body Composition Monitor (BCM) on Blood Pressure and Cardiac Condition in Hemodialysis Patients

Left Ventricular Hypertrophy

Turkey
Randolph Quinn

Completed

Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment

Renal Dialysis

United States
University of Giessen
Else Kröner Fresenius Foundation

Unknown

Elimination of Microemboli During Aortic Valve Replacement (ELMAR)

Neurocognitive Outcome After Aortic Valve Replacement

Germany
Fresenius Medical Care Deutschland GmbH
KLIFO GmbH

Not yet recruiting

Clinical Performance of the New Plasma Filter PX2 in TPE Treatments (plasmaFlux)

Autoimmune Diseases

Germany
Fresenius Medical Care Deutschland GmbH
Alcedis GmbH

Recruiting

Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients (Genius)

Renal Failure | End Stage Renal Disease | Acute Renal Failure

Germany
Xenios AG

Not yet recruiting

Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients (PulseSE)

Extracorporeal Membrane Oxygenation | Cardiogenic Shock | ECLS | VA ECMO

Germany
University Hospital Tuebingen
Else Kröner Fresenius Foundation

Completed

Binges and Neural Variability (BEDVAR)

Binge-Eating Disorder

Germany
Manchester University NHS Foundation Trust
Fresenius AG

Completed

Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy (PRISM)

Autoimmune Membranous Nephropathy

United Kingdom
University of Regensburg
Else Kröner Fresenius Foundation

Unknown

Prospective, Multicenter HCCIS Evaluation Study (HCCIS)

Hepatocellular Carcinoma

Clinical Trials Sponsored by Fresenius Kabi

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations